Increased protein levels of Bcl-2, Bcl-xL, and Mcl-1 have been suggested to protect cells against apoptosis in CML [41–43]. This evidence concerns the gene BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive.